OVERVIEW

The study predicts the short-term and long-term trends that can shape the future of structural heart devices market size that is expected to surpass USD 3.1 million by 2026 growing at a CAGR of 6.0 percent over the forecast period and this report will also account for Covid-19 implications as it acts as a key market contributor. Major factors contributing to the expansion of the worldwide market include the number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.

TABLE OF CONTENT

• 1 Global Hemostats Market
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Hemostats Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Hemostats Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Hemostats Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Hemostats Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Hemostats Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Hemostats Market ? By Product (Market Size ? & million/billion)
  • 8.1 Thrombin-based hemostats
  • 8.2 Oxidized regenerated cellulose based hemostats
  • 8.3 Combination hemostats
  • 8.4 Gelatin-based hemostats
  • 8.5 Collagen-based hemostats

• 9 Global Hemostats Market - By Formulation
  • 9.1 Matrix & gel hemostats
  • 9.2 Sheet & pad hemostats
  • 9.3 Sponge hemostats
  • 9.4 Powder hemostats

• 10 Global Hemostats Market - By Application
  • 10.1 Orthopedic surgery
  • 10.2 General surgery
  • 10.3 Neurological surgery
  • 10.4 Cardiovascular surgery
  • 10.5 Reconstructive surgery
  • 10.6 Gynecological surgery
  • 10.7 Other

• 11 Global Hemostats Market ? By Geography (Market Size ? & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Hemostats Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Hemostats Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 C. R. Bard
  • 13.3 B.Braun
  • 13.4 Baxter
  • 13.5 Gelita Medical GmbH
  • 13.6 Integra Lifesciences
  • 13.7 Marine Polymer Technologies
  • 13.8 Ethicon (Subsidiary of Johnson & Johnson)
  • 13.9 Teleflex Incorporated
  • 13.10 Pfizer
  • 13.11 Z-Medica, LLC
  • 13.12 Company 11 & more

• 14 Global Hemostats Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations